MBOT Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
241.0K
+129.5%
105.0K
0
0
0
Cost of Revenue
884.0K
+758.3%
103.0K
0
0
0
Gross Profit
-643000
-32250.0%
2.0K
0
0
0
Operating Expenses
5.5M
+28.3%
4.3M
+4.4%
4.1M
+7.2%
3.9M
+3.7%
3.7M
R&D
1.9M
+43.9%
1.3M
-16.1%
1.5M
+31.7%
1.2M
-44.5%
2.1M
SG&A
3.7M
+21.6%
3.0M
+16.7%
2.6M
-3.5%
2.7M
+66.9%
1.6M
Operating Income
-6188000
-43.2%
-4320000
-4.4%
-4138000
-7.2%
-3861000
-3.7%
-3723000
EBITDA
-6173000
-43.3%
-4308000
-4.4%
-4128000
-7.2%
-3851000
-3.8%
-3711000
Net Income
-5627000
-53.3%
-3671000
-6.0%
-3464000
+3.2%
-3577000
-2.2%
-3500000
EPS (Basic)
$-0.08
-60.0%
$-0.05
+0.0%
$-0.05
+28.6%
$-0.07
+30.0%
$-0.10
EPS (Diluted)
$-0.08
-60.0%
$-0.05
+0.0%
$-0.05
+28.6%
$-0.07
+30.0%
$-0.10
Shares (Diluted)
67.2M
+0.0%
67.2M
-0.5%
67.5M
+40.3%
48.1M
+31.8%
36.5M
Microbot Medical (MBOT) โ€” Financials